17 多级射频消融联合化疗粒子治疗原发性肝癌
作者:
通讯作者:
作者单位:

作者简介:

朱彤

基金项目:


Percutaneous radiofrequency ablation combined with interstitial hemotherapy for primary hepatic cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:探讨多级射频消融(RF) 联合化疗粒子对肝癌的治疗作用。
    方法:回顾性分析52例原发性肝癌采用B超引导下RF联合化疗粒子的治疗方法和效果。
    结果:全组无严重并发症或死亡者。50例(96.2%)随访24~48个月,84.7%患者自觉症状明显改善,57.7%的AFP值下降。术后1,2,3,4年生存率分别为 92%, 78%,56%,34%。
    结论:RF联合化疗粒子是治疗肝癌新的安全可靠有效的方法。

    Abstract:

    Abstract:Objective:To study the efficacy and indications of percutaneous radiofrequency ablation combined with interstitial chemotherapy for primary liver cancer.
    Methods :The clinical data of 52 cases with primary liver cancer treated by percutaneous radiofrequency combined with interstitial chemotherapy were analysed retrospectively.
    Results:Symptoms were significantly ameliorated in 85% of the patients. After the treatment, AFP level declined in 58% of the patients. The postoperative 1-,2-,3-,4-year surrival rate were 92%,78%,56%,43%, respectively.
    Conclusions:Percutaneous radiofrequency ablation combined with interstitial chemotherapy is a new safe, reliable and effective method for management of liver cancer.

    参考文献
    相似文献
    引证文献
引用本文

朱彤, 陈涛, 胡志前.17 多级射频消融联合化疗粒子治疗原发性肝癌[J].中国普通外科杂志,2007,16(7):17-.
DOI:10.7659/j. issn.1005-6947.2007.07.017

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2007-07-25